Dollars in Millions Except Per Share Amounts
Consolidated Statements of Income
For the years ended December 31,
Activo Circulante $ 4,397.00
Razon Circulante = = = 1.085411009627
2021 2020 Pasivo a corto plazo $ 4,051.00
Net sales $ 17,421 $ 16,471
Cost of sales 7,046 6,454 Activo ciculante - inventarios 2,705
Pruba de acido = = = 1.064418922306
Gross profit 10,375 10,017 Pasivo Corto plazo $ 4,051.00
Selling, general and administrative expenses 6,407 6,019
Other (income) expense, net 65 113 Efectivo y Equivalente $ 832.00
Goodwill and indefinite-lived intangible impairment charges Razon de Efectivo = = = 0.205381387312
571 - Pasivo corto Plazo $ 4,051.00
Operating profit 3,332 3,885
Non-service related postretirement costs 70 74
Interest (income) expense, net 175 164 Activo C - Pasivo C $ 346.00
Margen de seguridad = = = 0.085411009627
Income before income taxes 3,087 3,647 Pasivo Circulante $ 4,051.00
Provision for income taxes 749 787 Efec y eq, inv. Temp, clientes $ 832.00
Intervalo defensivo =
Net income including noncontrolling interests 2,338 2,860 Gastos de operación = $ 3,332.00 = 0.249699879952
Less: Net income attributable to noncontrolling interests 172 165
Net income attributable to Colgate-Palmolive Company $ 2,166 $ 2,695
Earnings per common share, basic $ 2.56 $ 3.15
Earnings per common share, diluted $ 2.55 $ 3.14
See Notes to Consolidated Financial Statements in the Company's Annual Report on Form 10-K.
LINK: https://investor.colgatepalmolive.com/financial-information/annual-reports
Dollars in Millions Except Share and Per Share Amounts
Consolidated Balance Sheets
As of December 31,
2021 2020
Assets
Current Assets
Cash and cash equivalents $ 832 $ 888
Receivables (net of allowances of $78 and $89,
respectively) 1,297 1,264
Inventories 1,692 1,673
Other current assets 576 513
Total current assets 4,397 4,338
Property, plant and equipment, net 3,730 3,716
Goodwill 3,284 3,824
Other intangible assets, net 2,462 2,894
Deferred income taxes 193 291
Other assets 974 857
Total assets $ 15,040 $ 15,920
Liabilities and Shareholders’ Equity
Current Liabilities
Notes and loans payable $ 39 $ 258
Current portion of long-term debt 12 9
Accounts payable 1,479 1,393
Accrued income taxes 436 403
Other accruals 2,085 2,341
Total current liabilities 4,051 4,404
Long-term debt 7,194 7,334
Deferred income taxes 395 426
Other liabilities 2,429 2,655
Total liabilities 14,069 14,819
Commitments and contingent liabilities - -
Shareholders’ Equity
Common stock, $1 par value
(2,000,000,000 shares authorized, 1,465,706,360 shares 1,466 1,466
issued)
Additional paid-in capital 3,269 2,969
Retained earnings 24,350 23,699
Accumulated other comprehensive income (loss) (4,386) (4,345)
Unearned compensation (1) (1)
Treasury stock, at cost (24,089) (23,045)
Total Colgate-Palmolive Company shareholders’ equity 609 743
Noncontrolling interests 362 358
Total equity 971 1,101
Total liabilities and equity $ 15,040 $ 15,920
See Notes to Consolidated Financial Statements in the Company's Annual Report on Form 10-K.
Dollars in Millions
Consolidated Statements of Cash Flow
For the years ended December 31,
2020 2020 2019
Operating Activities
Net income including noncontrolling interests $ 2,338 $ 2,860 $ 2,527
Adjustments to reconcile net income including noncontrolling interests
to net cash provided by operations:
Depreciation and amortization 556 539 519
Restructuring and termination benefits, net of cash (21) (71) 18
Stock-based compensation expense 135 107 100
Goodwill and indefinite-lived intangible impairment charges 571 - -
Loss on early extinguishment of debt 75 23 -
Deferred income taxes (132) (120) 17
Voluntary benefit plan contributions - - (113)
Cash effects of changes in:
Receivables (84) 138 19
Inventories (72) (251) (77)
Accounts payable and other accruals 14 520 36
Other non-current assets and liabilities (55) (26) 87
Net cash provided by operations 3,325 3,719 3,133
Investing Activities
Capital expenditures (567) (410) (335)
Purchases of marketable securities and investments (141) (143) (184)
Proceeds from sale of marketable securities and investments 141 124 131
Payment for acquisitions, net of cash acquired - (353) (1,711)
Other (25) 3 -
Net cash used in investing activities (592) (779) (2,099)
Financing Activities
Short-term borrowing/(repayment) less than 90 days - net (171) 488 296
Principal payments on debt (1) (703) (1,085) (1,441)
Proceeds from issuance of debt 699 - 2,578
Dividends paid (1,679) (1,654) (1,614)
Purchases of treasury shares (1,320) (1,476) (1,202)
Proceeds from exercise of stock options 424 874 498
Purchases of non-controlling interest in subsidiaries - (99) -
Other financing activities (24) 33 15
Net cash used in financing activities (2,774) (2,919) (870)
Effect of exchange rate changes on Cash and cash equivalents (15) (16) (7)
Net increase (decrease) in Cash and cash equivalents (56) 5 157
Cash and cash equivalents at beginning of year 888 883 726
Cash and cash equivalents at end of year $ 832 $ 888 $ 883
Supplemental Cash Flow Information
Income taxes paid $ 890 $ 845 $ 803
Interest paid $ 194 $ 188 $ 185
(1) For the year ended December 31, 2021 and 2020, Principal payments on debt includes cash charges of $75 and $20,
respectively, related to the extinguishment of debt prior to maturity. See Note 6, Long-Term Debt and Credit Facilities
for additional information.
See Notes to Consolidated Financial Statements in the Company's Annual Report on Form 10-K.
